Correlation Between Annexon and Arcus Biosciences
Can any of the company-specific risk be diversified away by investing in both Annexon and Arcus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annexon and Arcus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annexon and Arcus Biosciences, you can compare the effects of market volatilities on Annexon and Arcus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annexon with a short position of Arcus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annexon and Arcus Biosciences.
Diversification Opportunities for Annexon and Arcus Biosciences
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Annexon and Arcus is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Annexon and Arcus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcus Biosciences and Annexon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annexon are associated (or correlated) with Arcus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcus Biosciences has no effect on the direction of Annexon i.e., Annexon and Arcus Biosciences go up and down completely randomly.
Pair Corralation between Annexon and Arcus Biosciences
Given the investment horizon of 90 days Annexon is expected to under-perform the Arcus Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Annexon is 1.3 times less risky than Arcus Biosciences. The stock trades about -0.52 of its potential returns per unit of risk. The Arcus Biosciences is currently generating about -0.2 of returns per unit of risk over similar time horizon. If you would invest 1,783 in Arcus Biosciences on August 25, 2024 and sell it today you would lose (313.00) from holding Arcus Biosciences or give up 17.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Annexon vs. Arcus Biosciences
Performance |
| Timeline |
| Annexon |
| Arcus Biosciences |
Annexon and Arcus Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Annexon and Arcus Biosciences
The main advantage of trading using opposite Annexon and Arcus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annexon position performs unexpectedly, Arcus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcus Biosciences will offset losses from the drop in Arcus Biosciences' long position.| Annexon vs. Immix Biopharma | Annexon vs. Cns Pharmaceuticals | Annexon vs. Hepion Pharmaceuticals | Annexon vs. Day One Biopharmaceuticals |
| Arcus Biosciences vs. Cullinan Oncology LLC | Arcus Biosciences vs. Annexon | Arcus Biosciences vs. Structure Therapeutics American | Arcus Biosciences vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |